Distinct neural representations of placebo and nocebo effects

NeuroImage

Volumn 112, Issue , 2015, Pages 197-207

  Freeman, Sonya ^a   Yu, Rongjun ^a,c   Egorova, Natalia ^a   Chen, Xiaoyan ^a   Kirsch, Irving ^b   Claggett, Brian ^b   Kaptchuk, Ted J ^b   Gollub, Randy L ^a   Kong, Jian ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Expectancy; FMRI; Negative expectancy; Nocebo; Pain; Placebo; Positive expectancy

Indexed keywords

CAPSAICIN; LIDOCAINE; LOCAL ANESTHETIC AGENT;

ADULT; ARTICLE; BRAIN REGION; CEREBELLUM CORTEX; CORPUS STRIATUM; CREAM; DRUG EFFICACY; DRUG RESPONSE; EVOKED RESPONSE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; INSULA; MALE; NORMAL HUMAN; OCCIPITAL CORTEX; ORBITAL CORTEX; PAIN; PAIN ASSESSMENT; PERIAQUEDUCTAL GRAY MATTER; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; PUTAMEN; RATING SCALE; STIMULUS RESPONSE; BRAIN CORTEX; DRUG EFFECTS; HEAT; LEARNING; MIDDLE AGED; NERVOUS SYSTEM; NOCEBO EFFECT; NOCICEPTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; PLACEBO EFFECT; PSYCHOLOGY; REWARD; YOUNG ADULT;

ADULT; ANESTHETICS, LOCAL; CAPSAICIN; CEREBRAL CORTEX; FEMALE; HOT TEMPERATURE; HUMANS; LIDOCAINE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVOUS SYSTEM; NOCEBO EFFECT; PAIN; PAIN PERCEPTION; PERIAQUEDUCTAL GRAY; PLACEBO EFFECT; REWARD; SET (PSYCHOLOGY); YOUNG ADULT;

EID: 84925126225     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2015.03.015     Document Type: Article

References (76)

1. Akitsuki Y., Sugiura M., Watanabe J., Yamashita K., Sassa Y., Awata S., Matsuoka H., Maeda Y., Matsue Y., Fukuda H., Kawashima R. Context-dependent cortical activation in response to financial reward and penalty: an event-related fMRI study. Neuroimage 2003, 19:1674-1685.
2. Amanzio M., Corazzini L.L., Vase L., Benedetti F. A systematic review of adverse events in placebo groups of anti-migraine clinical trials. Pain 2009, 146:261-269.
3. Amanzio M., Benedetti F., Porro C.A., Palermo S., Cauda F. Activation likelihood estimation meta-analysis of brain correlates of placebo analgesia in human experimental pain. Hum. Brain Mapp. 2013, 34:738-752.
4. Atlas L.Y., Wager T.D. How expectations shape pain. Neurosci. Lett. 2012, 520:140-148.
5. Atlas L.Y., Whittington R.A., Lindquist M.A., Wielgosz J., Sonty N., Wager T.D. Dissociable influences of opiates and expectations on pain. J. Neurosci. 2012, 32:8053-8064.
6. Barsky A.J., Saintfort R., Rogers M.P., Borus J.F. Nonspecific medication side effects and the nocebo phenomenon. JAMA 2002, 287:622-627.
7. Baur V., Hanggi J., Langer N., Jancke L. Resting-state functional and structural connectivity within an insula-amygdala route specifically index state and trait anxiety. Biol. Psychiatry 2013, 73:85-92.
8. Behrens T.E., Johansen-Berg H., Woolrich M.W., Smith S.M., Wheeler-Kingshott C.A., Boulby P.A., Barker G.J., Sillery E.L., Sheehan K., Ciccarelli O., Thompson A.J., Brady J.M., Matthews P.M. Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat. Neurosci. 2003, 6:750-757.
9. Benedetti F. Mechanisms of placebo and placebo-related effects across diseases and treatments. Annu. Rev. Pharmacol. Toxicol. 2008, 48:33-60.
10. Benedetti F. Placebo Effects: Understanding the Mechanism in Health and Disease 2009, Oxford University Press, New York.
11. Benedetti F., Amanzio M., Casadio C., Oliaro A., Maggi G. Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide. Pain 1997, 71:135-140.
12. Benedetti F., Pollo A., Lopiano L., Lanotte M., Vighetti S., Rainero I. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J. Neurosci. 2003, 23:4315-4323.
13. Benedetti F., Amanzio M., Vighetti S., Asteggiano G. The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J. Neurosci. 2006, 26:12014-12022.
14. Benedetti F., Durando J., Vighetti S. Nocebo and placebo modulation of hypobaric hypoxia headache involves the cyclooxygenase-prostaglandins pathway. Pain 2014, 155:921-928.
15. Bingel U., Wanigasekera V., Wiech K., Mhuircheartaigh R.N., Lee M.C., Ploner M., Tracey I. The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci. Transl. Med. 2011, 3:70ra14.
16. Brodersen K.H., Wiech K., Lomakina E.I., Lin C.S., Buhmann J.M., Bingel U., Ploner M., Stephan K.E., Tracey I. Decoding the perception of pain from fMRI using multivariate pattern analysis. Neuroimage 2012, 63:1162-1170.
17. Brody H., Miller F.G. Lessons from recent research about the placebo effect-from art to science. JAMA 2011, 306:2612-2613.
18. Buchel C., Geuter S., Sprenger C., Eippert F. Placebo analgesia: a predictive coding perspective. Neuron 2014, 81:1223-1239.
19. Carlino E., Frisaldi E., Benedetti F. Pain and the context. Nat. Rev. Rheumatol. 2014, 10:348-355.
20. Cleophas T.J. The importance of placebo effects. JAMA 1995, 273:283.
21. Colloca L., Benedetti F. Nocebo hyperalgesia: how anxiety is turned into pain. Curr. Opin. Anaesthesiol. 2007, 20:435-439.
22. Colloca L., Finniss D. Nocebo effects, patient-clinician communication, and therapeutic outcomes. JAMA 2012, 307:567-568.
23. Colloca L., Sigaudo M., Benedetti F. The role of learning in nocebo and placebo effects. Pain 2008, 136:211-218.
24. Colloca L., Petrovic P., Wager T.D., Ingvar M., Benedetti F. How the number of learning trials affects placebo and nocebo responses. Pain 2010, 151:430-439.
25. de la Fuente-fernandex R., Schulzer M., Stoessl A.J. The placebo effect in neurological disorders. Lancet Neurol. 2002, 1:85-91.
26. Di Blasi Z., Harkness E., Ernst E., Georgiou A., Kleijnen J. Influence of context effects on health outcomes: a systematic review. Lancet 2001, 357:757-762.
27. Eippert F., Bingel U., Schoell E.D., Yacubian J., Klinger R., Lorenz J., Buchel C. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 2009, 63:533-543.
28. Enck P., Benedetti F., Schedlowski M. New insights into the placebo and nocebo responses. Neuron 2008, 59:195-206.
29. Fairhurst M., Wiech K., Dunckley P., Tracey I. Anticipatory brainstem activity predicts neural processing of pain in humans. Pain 2007, 128:101-110.
30. Fields H.L. Pain modulation: expectation, opioid analgesia and virtual pain. Prog. Brain Res. 2000, 122:245-253.
31. Finniss D.G., Benedetti F. Mechanisms of the placebo response and their impact on clinical trials and clinical practice. Pain 2005, 114:3-6.
32. Finniss D.G., Kaptchuk T.J., Miller F., Benedetti F. Biological, clinical, and ethical advances of placebo effects. Lancet 2010, 375:686-695.
33. Friston K.J., Penny W.D., Glaser D.E. Conjunction revisited. Neuroimage 2005, 25:661-667.
34. Geuter S., Buchel C. Facilitation of pain in the human spinal cord by nocebo treatment. J. Neurosci. 2013, 33:13784-13790.
35. Gondo M., Moriguchi Y., Kodama N., Sato N., Sudo N., Kubo C., Komaki G. Daily physical complaints and hippocampal function: an fMRI study of pain modulation by anxiety. Neuroimage 2012, 63:1011-1019.
36. Gracely R.H., McGrath P.A., Dubner R. Ratio scales of sensory and affective verbal pain descriptors. Pain 1978, 5:5-18.
37. Gracely R.H., McGrath P.A., Dubner R. Validity and sensitivity of ratio scales of sensory and affective verbal pain descriptors: manipulation of affect by diazepam. Pain 1978, 5:19-29.
38. Hahn A., Stein P., Windischberger C., Weissenbacher A., Spindelegger C., Moser E., Kasper S., Lanzenberger R. Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorder. Neuroimage 2011, 56:881-889.
39. Kam-Hansen S., Jakubowski M., Kelley J.M., Kirsch I., Hoaglin D.C., Kaptchuk T.J., Burstein R. Altered placebo and drug labeling changes the outcome of episodic migraine attacks. Sci. Transl. Med. 2014, 6:218ra215.
40. Kaptchuk T.J. Powerful placebo: the dark side of the randomised controlled trial. Lancet 1998, 351:1722-1725.
41. Kong J., Gollub R.L., Rosman I.S., Webb J.M., Vangel M.G., Kirsch I., Kaptchuk T.J. Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. J. Neurosci. 2006, 26:381-388.
42. Kong J., Kaptchuk T.J., Polich G., Kirsch I., Gollub R.L. Placebo analgesia: findings from brain imaging studies and emerging hypotheses. Rev. Neurosci. 2007, 18:173-190.
43. Kong J., Gollub R.L., Polich G., Kirsch I., Laviolette P., Vangel M., Rosen B., Kaptchuk T.J. A functional magnetic resonance imaging study on the neural mechanisms of hyperalgesic nocebo effect. J. Neurosci. 2008, 28:13354-13362. (PMCID: PMC2649754).
44. Kong J., Kaptchuk T.J., Webb J.M., Kong J.T., Sasaki Y., Polich G.R., Vangel M.G., Kwong K., Rosen B., Gollub R.L. Functional neuroanatomical investigation of vision-related acupuncture point specificity-a multisession fMRI study. Hum. Brain Mapp. 2009, 30:38-46.
45. Kong J., Kaptchuk T.J., Polich G., Kirsch I., Vangel M., Zyloney C., Rosen B., Gollub R.L. An fMRI study on the interaction and dissociation between expectation of pain relief and acupuncture treatment. Neuroimage 2009, 47:1066-1076. (PMID: 19501656).
46. Kong J., Tu P.C., Zyloney C., Su T.P. Intrinsic functional connectivity of the periaqueductal gray, a resting fMRI study. Behav. Brain Res. 2010, 211:215-219.
47. Kong J., Loggia M.L., Zyloney C., Tu P., Laviolette P., Gollub R.L. Exploring the brain in pain: activations, deactivations and their relation. Pain 2010, 148:257-267. (PMID: 20005043).
48. Kong J., Jensen K., Loiotile R., Cheetham A., Wey H.Y., Tan T., Rosen B., Smoller J.S., Kaptchuk T.J., Gollub R. Functional connectivity of frontoparietal network predicts cognitive modulation of pain. Pain 2013, 154:459-467.
49. Leknes S., Lee M., Berna C., Andersson J., Tracey I. Relief as a reward: hedonic and neural responses to safety from pain. PLoS One 2011, 6:e17870.
50. Miller F.G., Colloca L., Kaptchuk T.J. The placebo effect: illness and interpersonal healing. Perspect. Biol. Med. 2009, 52:518-539.
51. Nichols T., Brett M., Andersson J., Wager T., Poline J.B. Valid conjunction inference with the minimum statistic. Neuroimage 2005, 25:653-660.
52. Nieuwenhuis S., Heslenfeld D.J., von Geusau N.J., Mars R.B., Holroyd C.B., Yeung N. Activity in human reward-sensitive brain areas is strongly context dependent. Neuroimage 2005, 25:1302-1309.
53. Ochsner K.N., Ludlow D.H., Knierim K., Hanelin J., Ramachandran T., Glover G.C., Mackey S.C. Neural correlates of individual differences in pain-related fear and anxiety. Pain 2006, 120:69-77.
54. O'Doherty J., Dayan P., Schultz J., Deichmann R., Friston K., Dolan R.J. Dissociable roles of ventral and dorsal striatum in instrumental conditioning. Science 2004, 304:452-454.
55. Petersen G.L., Finnerup N.B., Colloca L., Amanzio M., Price D.D., Jensen T.S., Vase L. The magnitude of nocebo effects in pain: a meta-analysis. Pain 2014, 155:1426-1434.
56. Petrovic P. Placebo analgesia and nocebo hyperalgesia - two sides of the same coin?. Pain 2008, 136:5-6.
57. Petrovic P., Dietrich T., Fransson P., Andersson J., Carlsson K., Ingvar M. Placebo in emotional processing-induced expectations of anxiety relief activate a generalized modulatory network. Neuron 2005, 46:957-969.
58. Ploghaus A., Narain C., Beckmann C.F., Clare S., Bantick S., Wise R., Matthews P.M., Rawlins J.N., Tracey I. Exacerbation of pain by anxiety is associated with activity in a hippocampal network. J. Neurosci. 2001, 21:9896-9903.
59. Pollo A., Amanzio M., Arslanian A., Casadio C., Maggi G., Benedetti F. Response expectancies in placebo analgesia and their clinical relevance. Pain 2001, 93:77-84.
60. Price D.D., Finniss D.G., Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu. Rev. Psychol. 2008, 59:565-590.
61. Schmid J., Theysohn N., Gass F., Benson S., Gramsch C., Forsting M., Gizewski E.R., Elsenbruch S. Neural mechanisms mediating positive and negative treatment expectations in visceral pain: a functional magnetic resonance imaging study on placebo and nocebo effects in healthy volunteers. Pain 2013, 154:2372-2380.
62. Schweinhardt P., Seminowicz D.A., Jaeger E., Duncan G.H., Bushnell M.C. The anatomy of the mesolimbic reward system: a link between personality and the placebo analgesic response. J. Neurosci. 2009, 29:4882-4887.
63. Scott D.J., Stohler C.S., Egnatuk C.M., Wang H., Koeppe R.A., Zubieta J.K. Individual differences in reward responding explain placebo-induced expectations and effects. Neuron 2007, 55:325-336.
64. Scott D.J., Stohler C.S., Egnatuk C.M., Wang H., Koeppe R.A., Zubieta J.K. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch. Gen. Psychiatry 2008, 65:220-231.
65. Shah S.G., Klumpp H., Angstadt M., Nathan P.J., Phan K.L. Amygdala and insula response to emotional images in patients with generalized social anxiety disorder. J. Psychiatry Neurosci. 2009, 34:296-302.
66. Sladky R., Hoflich A., Kublbock M., Kraus C., Baldinger P., Moser E., Lanzenberger R., Windischberger C. Disrupted effective connectivity between the amygdala and orbitofrontal cortex in social anxiety disorder during emotion discrimination revealed by dynamic causal modeling for fMRI. Cereb. Cortex 2015, 25:895-903.
67. Stein M.B., Simmons A.N., Feinstein J.S., Paulus M.P. Increased amygdala and insula activation during emotion processing in anxiety-prone subjects. Am. J. Psychiatry 2007, 164:318-327.
68. Thomas K.B. The placebo in general practice. Lancet 1994, 344:1066-1067.
69. Tracey I. Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans. Nat. Med. 2010, 16:1277-1283.
70. Tzourio-Mazoyer N., Herve P.Y., Mazoyer B. Neuroanatomy: tool for functional localization, key to brain organization. Neuroimage 2007, 37:1059-1060. (discussion 1066-1058).
71. Wager T.D., Rilling J.K., Smith E.E., Sokolik A., Casey K.L., Davidson R.J., Kosslyn S.M., Rose R.M., Cohen J.D. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 2004, 303:1162-1167.
72. Wager T.D., Atlas L.Y., Lindquist M.A., Roy M., Woo C.W., Kross E. An fMRI-based neurologic signature of physical pain. N. Engl. J. Med. 2013, 368:1388-1397.
73. Wagner K., Frings L., Quiske A., Unterrainer J., Schwarzwald R., Spreer J., Halsband U., Schulze-Bonhage A. The reliability of fMRI activations in the medial temporal lobes in a verbal episodic memory task. Neuroimage 2005, 28:122-131.
74. Wrobel N., Wiech K., Forkmann K., Ritter C., Bingel U. Haloperidol blocks dorsal striatum activity but not analgesia in a placebo paradigm. Cortex 2014, 57:60-73.
75. Yu R., Gollub R.L., Vangel M., Kaptchuk T., Smoller J.W., Kong J. Placebo analgesia and reward processing: integrating genetics, personality, and intrinsic brain activity. Hum. Brain Mapp. 2014, 35:4583-4593.
76. Zubieta J.K., Stohler C.S. Neurobiological mechanisms of placebo responses. Ann. N. Y. Acad. Sci. 2009, 1156:198-210.